<?xml version='1.0' encoding='utf-8'?>
<document id="13348"><sentence text="Drug-drug interactions among residents in homes for the elderly: a pilot study." /><sentence text="This pilot study investigated epidemiologically the potential for clinically significant drug-drug interactions, a subclass of adverse drug responses, in two homes for the elderly" /><sentence text=" The agent (drugs), host (residents), and environment (rural and urban nursing homes) in the illness known as drug-drug interaction were studied" /><sentence text=" Drug profiles on 188 subjects were compiled and screened by computer" /><sentence text=" Of these, 100 (80 in the rural home and 20 in the urban home) had the potential for clinically significant drug-drug interactions" /><sentence text=" Laboratory diagnostic procedures essential to confirm the unintentional interaction of two or more drugs were beyond the scope of the study; therefore, physicians independently reviewed the records of 66 residents who could be interviewed, agreeing that 27 residents were potential drug-drug interactors" /><sentence text=" These subjects had twice as many drug products and three times as many pro re nata products prescribed for them as did subjects without the potential for drug-drug interaction" /><sentence text=" The possible cause of interaction found most frequently was digitalis combined with thiazide or furosemide"><entity charOffset="85-93" id="DDI-PubMed.13348.s8.e0" text="thiazide" /><entity charOffset="97-107" id="DDI-PubMed.13348.s8.e1" text="furosemide" /><pair ddi="false" e1="DDI-PubMed.13348.s8.e0" e2="DDI-PubMed.13348.s8.e0" /><pair ddi="false" e1="DDI-PubMed.13348.s8.e0" e2="DDI-PubMed.13348.s8.e1" /></sentence><sentence text=" The results of this pilot study suggest several implications for practice within the research setting" /><sentence text="" /></document>